Heart Disease News and Research

Latest Heart Disease News and Research

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

30 Jun 2010

Study highlights importance of individualized, patient-centered therapies

In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar.

30 Jun 2010

Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs

New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and those that act on non-sodium channel-targets.

30 Jun 2010

2 new studies add to evidence of risks with diabetes drug Avandia as FDA prepares to debate it's safety

The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.

30 Jun 2010

Lack of reimbursements limit drug-eluting stent market across Latin America

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.

30 Jun 2010

Qigong and Tai Chi offer physical and mental health benefits

An across-the-board review of the health effects of Qigong and Tai Chi finds these practices offer many physical and mental health advantages with benefits for the heart, immune system and overall quality of life.

30 Jun 2010

U.S., China open Shanghai Epidemiology Center for chronic, epidemic diseases

Chinese and U.S. health officials opened an epidemiology center in Shanghai Tuesday to train experts to deal with and prevent chronic and epidemic diseases, the Associated Press reports.

30 Jun 2010

Study evaluates potential risks and benefits of moderate alcohol consumption

A discussion by renowned epidemiologist Kenneth Mukamal has recently been published in the Journal of the American Medical Association, JAMA. It provides a discussion in response to a theoretical question, - if you are a 42 year old male, should you drink alcohol ( in moderation) for your health?

30 Jun 2010

Seventh Annual HealthGrades Maternity Care in Hospitals Study ranks Good Samaritan in top 5%

Good Samaritan Hospital's maternity care is in the top 5 percent in the nation for the third year in a row according to a new study issued today by HealthGrades, Inc., the independent ratings organization. The Seventh Annual HealthGrades Maternity Care in Hospitals Study used state-government data to compare hospitals in terms of complication rates for vaginal and C-section deliveries as well as neonatal mortality.

30 Jun 2010

News round up: UniCare will drop health coverage for Virginians; Hawaii concerned about lack of physicians

The Washington Post: "About 3,000 Virginians who have health insurance through UniCare, a private insurer, will lose that coverage Jan. 1, a UniCare spokesman said Monday. Most live in Northern Virginia and get their coverage through the individual market, officials said.

30 Jun 2010

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

30 Jun 2010

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Wishard Health Services, the nation's third-largest safety net health care system in outpatient visits, and the Regenstrief Institute Inc., an internationally-respected medical and public health informatics innovator, earned the NAPH 2010 President's Award for Health Reform Readiness and Leadership.

30 Jun 2010

Cardio3 BioSciences reports positive data from C-Cure stem cell therapy clinical trial for heart failure

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular diseases, today announces positive safety data and preliminary efficacy results from its clinical trial of C-Cure(R), a breakthrough stem cell therapy for heart failure.

30 Jun 2010

COBRA, jobs bill in further jeopardy after death of Sen. Byrd

Roll Call: The death of Sen. Robert Byrd, D-W. Va., has jeopardized further the passage of some bills in Congress, including a bill that would extend unemployment benefits. "Democratic leaders have been thwarted numerous times in recent weeks on jobs legislation, despite scaling down the measure dramatically after Republicans and some moderate Democrats balked at adding to the deficit.

30 Jun 2010

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100, intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark.

30 Jun 2010

Importance of cell-cell communication in ischaemia

A team from the Bristol Heart Institute have investigated the importance of cell-cell communication in regulating the formation of new blood vessels following the restriction in blood supply to the heart or back leg in mice.

29 Jun 2010

USPTO grants Vermillion Alzheimer's disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.

29 Jun 2010

Siemens Radiation Reduction Alliance launched

In a continual commitment to patient care and radiation reduction in computed tomography (CT), Siemens Healthcare has launched SIERRA (Siemens Radiation Reduction Alliance) and has established an expert panel to advance the cause of dose reduction in CT. The new Low Dose Expert Panel includes 15 specialists in radiology, cardiology and physics, who are internationally recognized for their publications on the subject of CT dose.

29 Jun 2010

Claros point-of-care system for PSA receives European CE Mark approval

Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.

29 Jun 2010

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.

29 Jun 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Study highlights importance of individualized, patient-centered therapies

Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs

2 new studies add to evidence of risks with diabetes drug Avandia as FDA prepares to debate it's safety

Lack of reimbursements limit drug-eluting stent market across Latin America

Qigong and Tai Chi offer physical and mental health benefits

U.S., China open Shanghai Epidemiology Center for chronic, epidemic diseases

Study evaluates potential risks and benefits of moderate alcohol consumption

Seventh Annual HealthGrades Maternity Care in Hospitals Study ranks Good Samaritan in top 5%

News round up: UniCare will drop health coverage for Virginians; Hawaii concerned about lack of physicians

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Cardio3 BioSciences reports positive data from C-Cure stem cell therapy clinical trial for heart failure

COBRA, jobs bill in further jeopardy after death of Sen. Byrd

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

Importance of cell-cell communication in ischaemia

USPTO grants Vermillion Alzheimer's disease biomarker patent

Siemens Radiation Reduction Alliance launched

Claros point-of-care system for PSA receives European CE Mark approval

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in